Published: Dec 13, 2023, 20:05 IST | Updated: Dec 13, 2023, 20:05 IST
Researchers at the University of Hong Kong have claimed to be the first in the world to prolong the life of a late-stage liver cancer patient by using a new treatment strategy that reduces the tumor to a state suitable for a transplant.